Company Overview
Bioinduction Limited is listed at the official companies registry as in Liquidation Private Limited Company. The company was incorporated on Wednesday 01 May 2002, so this is a well established company. Bioinduction Limited has been in business for 23 years and 11 months. The accounts status is total exemption full and the accounts are next due on Tuesday 30 September 2025.
Registered Address

James Cowper Kreston The White Building, 1-4 Cumberland Place, Southampton, SO15 2NP
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameBIOINDUCTION LIMITED
Company Number04429471
Registered Office AddressJames Cowper Kreston The White Building
 1-4 Cumberland Place
 SO15 2NP
Company CategoryPrivate Limited Company
Company StatusLiquidation
Country of OriginUnited Kingdom
Incorporation Date01/05/2002
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2025
Accounts Last Made Up Date31/12/2023
Accounts Account CategoryTOTAL EXEMPTION FULL
Returns Next Due Date29/05/2017
Returns Last Made Up Date01/05/2016
Directors & Members
Show Resigned
Aidan Crawley - Director
(British, 43 years old, born October 1983)
Appointed 25 July 2023
 Active
Tim Denison - Director
(American, 56 years old, born July 1970)
Appointed 25 July 2023
 Active
Secretaries
Show Resigned
Other Company Directorships
Aidan Crawley
AMBER THERAPEUTICS HOLDINGS LIMITED
AMBER THERAPEUTICS LIMITED
BASISYIELD LLP
BIOINDUCTION MEDICAL LIMITED
Tim Denison
AMBER THERAPEUTICS HOLDINGS LIMITED
AMBER THERAPEUTICS LIMITED
BIOINDUCTION MEDICAL LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Dec-2023 31-Mar-2022 31-Mar-2021
Balance Sheet
Fixed Assets 6,676 6,676 10,233
Current Assets 555,387 555,387 249,507
Creditors Due Within One Year 93,963 93,963 50,609
Working Cap 461,424 461,424 198,898
Total Assets Less Current Liabilities 468,100 468,100 209,131
Long-term Liabilities 1,321 1,321 1,997
Net Assets 466,779 466,779 207,134
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 466,779 466,779 207,134
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2023 31-Mar-2022 31-Mar-2021
Tangible Fixed Assets - - -
Fixed Assets 1.2% 1.2% 3.9%
Stocks Inventory - - -
Debtors 69.0% 69.0% 94.6%
Cash Bank In Hand 29.8% 29.8% 1.4%
Current Assets 98.8% 98.8% 96.1%
Creditors Due Within One Year 16.7% 16.7% 19.5%
Net Current Assets Liabilities 82.1% 82.1% 76.6%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds 83.0% 83.0% 79.7%
Capital Employed - - -
Total Assets Less Current Liabilities 83.3% 83.3% 80.5%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2023 31-Mar-2022 31-Mar-2021
Liquidity Ratio 5.9 5.9 4.9
Solvency Ratio 5.9 5.9 4.9
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 1
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 1
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2023 31-Mar-2022 31-Mar-2021
Assets 562,063 562,063 259,740
Debt 95,284 95,284 52,606
Net Assets/Debt 466,779 466,779 207,134

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations. The latest accounts are not up-to-date. Later accounts are now overdue. Late filing is not a positive factor. Analysis based on the latest figures available must be taken in the context that the figures are not up-to-date. Information provided by Companies House shows Liquidation.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations. The latest accounts are not up-to-date. Later accounts are now overdue. Late filing is not a positive factor. Analysis based on the latest figures available must be taken in the context that the figures are not up-to-date. Information provided by Companies House shows Liquidation.  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations. The latest accounts are not up-to-date. Later accounts are now overdue. Late filing is not a positive factor. Analysis based on the latest figures available must be taken in the context that the figures are not up-to-date. Information provided by Companies House shows Liquidation.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around SO15 2NP
CAPE ARGUS LIMITED
White Building 1-4 Cumberland Place, Southampton, Hampshire, SO15 2NP
EVEI SERVICES LIMITED
C/O James Cowper Kreston White Building, 1-4 Cumberland Place, Southampton, SO15 2NP
INTERFAST EUROPE LIMITED
The White Building, 1-4 Cumberland Place, Southampton, SO15 2NP
WHALEPLY LIMITED
JAMES COWPER KRESTON, White Building 1-4 Cumberland Place, Southampton, Hampshire, SO15 2NP
RIVERSIMPLE LTD
The White Building, 1-4 Cumberland Place, Southampton, Hampshire, SO15 2NP
AMENCO (POOLE) LIMITED
JAMES COMPER KRESTON, White Building 1-4 Cumberland Place, Southampton, Hampshire, SO15 2NP
FIRST RESERVE POWER LIMITED
The White Building, 1-4 Cumberland Place, Southampton, Hampshire, SO15 2NP
EIDER HOMES LIMITED
White Building 1-4 Cumberland Place, Southampton, Hampshire, SO15 2NP
SYNTHETIC FLOORING LIMITED
JAMES COWPER KRESTON, White Building 1-4 Cumberland Place, Southampton, Hampshire, SO15 2NP
BLACK LION INVESTMENTS LTD
The White Building 1-4, Cumberland Place, Southampton, Hampshire, SO15 2NP
Document Filings
Return of final meeting in a Members' voluntary winding up
Registered office address changed from 178-180 Hotwell Road Bristol BS8 4RP to James Cowper Kreston the White Building 1-4 Cumberland Place Southampton SO15 2NP on 17 June 2025
Declaration of solvency
Appointment of a voluntary liquidator
Resolutions
Confirmation statement made on 12 March 2025 with no updates
Notification of Amber Therapeutics Holdings Limited as a person with significant control on 11 July 2024
Resolutions
Confirmation statement made on 12 March 2024 with updates
Current accounting period shortened from 31 March 2024 to 31 December 2023
Appointment of Mr Tim Denison as a director on 25 July 2023
Appointment of Mr Aidan Harold Winston Crawley as a director on 25 July 2023
Termination of appointment of Nikunj Kantilal Patel as a director on 25 July 2023
Termination of appointment of Jonathan Paul Ottaway as a director on 25 July 2023
Termination of appointment of Anton Jonathon William Jenkins as a director on 25 July 2023
Termination of appointment of Ivor Stephen Gillbe as a director on 25 July 2023
Notification of Amber Therapeutics Ltd as a person with significant control on 25 July 2023
Cessation of Ivor Stephen Gillbe as a person with significant control on 25 July 2023
Satisfaction of charge 044294710001 in full
Confirmation statement made on 1 May 2023 with updates
Registration of charge 044294710001, created on 17 May 2023
Memorandum and Articles of Association
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free